Pharmaceuticals

#Cannabinoid #Medicinal cannabis #Pharmaceuticals

GW Pharmaceuticals’ cannabidiol treatment for seizures approved

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a new indication for GW Pharmaceutical’s cannabidiol as an adjunctive treatment of seizures associated with tuberous sclerosis complex (TSC), for patients two years of age and older. GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an… Read More

#News

#AI / data analytics / healthtech / informatics #Biotechnology #Pharmaceuticals #Technology

AI-powered indication expansion partnership entered

Healx has partnered with Ono Pharmaceutical to leverage Healx’s indication expansion technology to identify new disease indications with high unmet needs that could be treated by Ono’s assets. Healx’s AI drug discovery platform, Healnet, integrates data from multiple sources – including biomedical research, patient insight, scientific literature and curated proprietary… Read More

#News

#Cancer research #Oncology #Pharmaceuticals

Appointment strengthens the experience of RareCan

RareCan, a new company accelerating research into rare cancers, has appointed Dr Anita Cooper as Non-Executive Director. The appointment is said to strengthen the scientific and pharmaceutical experience of RareCan’s board in support of the company’s planned commercial growth. With over 30 years’ global business experience, Cooper has worked across… Read More

#Business & Investment #Cancer Research #News

#Biotechnology #Clinical trials #Data #Microbiology #Pharmaceuticals

Cardiac patients receiving nasal gel showed reduction of S. aureus

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel medicines that can prevent life threatening infections, has released data from its recent Phase IIb clinical trial. In March 2021, the company announced that this study had met its primary endpoint, demonstrating a reduction of 2.5 log… Read More

#News

#Biochemistry #Drug development #Drug discovery #Life sciences #Microfluidics #Pharmaceuticals

Researchers develop tool to speed up the study of enzymes

Scientists understand that transformations that couldn’t historically be explained by conventional chemistry or physics alone are in fact powered by enzymes – protein molecules comprised of chains of amino acids that act to speed up, or catalyse, the conversion of one kind of molecule (substrates) into another (products). While more… Read More

#News

#Covid-19 #Drug development #Drug discovery #Pharmaceuticals #RNA #SARS-CoV-2

SARS-CoV-2 spike protein induces lipid stripping from cell membrane

Scientists at the Institut Laue-Langevin (ILL), in collaboration with the Paul Scherrer Institut (PSI), the Institut de Biologie Structurale (IBS) and the Australian Nuclear Science and Technology Organisation (ANSTO), have published new data on how the SARS-CoV-2 spike protein interacts with mammalian lung cell membranes, allowing the viral… Read More

#Covid-19 #News #Trending News

#Biopharmaceuticals #Biotechnology #Drug development #Investment #Pharmaceuticals #Therapeutics

New laboratory boosts high-potency drug development

US-based Continuus Pharmaceuticals has opened a new laboratory space and new technology to help the development of high-potency drugs. The new lab and technology are the latest developments in Continuus’ ongoing expansion, coming six months after receiving a US$69.3 million US government contract for the domestic production of medicines. “Our… Read More

#News

#Awards #Biotechnology #Pharmaceuticals

Biotech company win Tech-Xpo 2021

Ferryx won ‘Best Elevator Pitch’ at SETsquared Bristol’s Tech-Xpo. Tech-Xpo is a flagship pitch, demo, connect showcase, providing a platform for start-ups to showcase their innovative technologies and raise investment in Bristol, UK. Founded in 2019 as a spin-out from the University of Bristol, Ferryx is dealing with the lack… Read More

#News #Start-up Zone

#AI / data analytics / healthtech / informatics #Biopharmaceuticals #Drug delivery #Drug development #Pharma #Pharmaceuticals

Half of pharma believes AI can help bring new drugs to market faster

New research reveals that 50% of European and US pharmaceutical manufacturing companies know artificial intelligence (AI) can help bring new drugs to market more rapidly and securely, but 96% face challenges with using it to derive value from their data. 49% of all executives surveyed say their company has no… Read More

#News

#Biopharmaceutical #Pharmaceuticals

UK’s ABPI releases ‘substantial overhaul’ to Code of Practice

The President of the UK’s Association of the British Pharmaceutical Industry (ABPI) has announced that its 2021 Code of Practice puts new emphasis on the ABPI’s principles. “We want everyone in pharmaceutical companies to live and breathe these from leadership teams and commercial leads to admin assistants and research scientists. Read More

#News

#HIV #Immunology #Infectious diseases #Oncology #Pharmaceuticals

New GSK to deliver step-change in growth and performance

GlaxoSmithKline has announced New GSK, which will deliver step-change in growth and performance over next ten years, driven by a high-quality Vaccines and Specialty Medicines portfolio and late-stage pipeline. New GSK will keep a 20% stake in the consumer healthcare business. The Independent confirmed: “The unit will be listed on… Read More

#News

#Cancer research #Clinical trials #Immunotherapy #Oncology #Pharmaceuticals

Unlocking the potential for autologous vaccines

In the last decade, cancer immunotherapy has emerged as one the most promising treatments for the disease. In a recent pilot study, Professor Joachim Drevs and his co-authors; Joachim Ahlers, Eglys Gonzalez Marcano and Leona Kröhle describe how a new autologous vaccine developed in partnership with cancer clinic RGCC created… Read More

#Cancer Research #Editor's Choice #Exclusive Content #News #Opinion

#AI / data analytics / healthtech / informatics #Data #Database #Pharmaceuticals

Pharmaceutical companies lack digital ability

Nearly half of pharmaceutical companies (48%) admit their competitiveness suffers because they cannot extract or use insights from data they already have within their business. An equal percentage (48%) admit they do not use their own data for business decisions as well as they could. The findings are from research… Read More

#News

#Cancer #Cancer research #Drug delivery #Drug innovation #London Cancer Hub #Pharmaceuticals

Global hub for cancer research, treatment and commercial enterprise

Andy Carr, Business Development Manager at The Institute of Cancer Research, London, introduces the new Innovation Gateway at The London Cancer Hub in Sutton, south London, to DDW’s Megan Thomas. MT: I understand the establishment of the Innovation Gateway is underway. What is the progress and when is it due… Read More

#Cancer Research #Editor's Choice #Exclusive Content #News

#Big pharma #Biotechnology #Pharmaceuticals

Sygnature Discovery expands US presence to Bay Area biotech hub

Sygnature Discovery, an integrated discovery and pre-clinical solutions provider, has a new office in South San Francisco’s biotech hub at Oyster Point, where it says it can better serve current and future clients on the US west coast. The company has grown in the previous year, having recently expanded… Read More

#News